Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant Treatment

Simple Summary The use of neoadjuvant therapy (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC) is increasing. Objective quantification of the histopathological response to NAT may be used to guide adjuvant treatment and compare the efficacy of neoadjuvant regimens. However, current tum...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancers 2021-10, Vol.13 (20), p.5089, Article 5089
Hauptverfasser:	Janssen, Boris, Theijse, Rutger, van Roessel, Stijn, de Ruiter, Rik, Berkel, Antonie, Huiskens, Joost, Busch, Olivier R., Wilmink, Johanna W., Kazemier, Geert, Valkema, Pieter, Farina, Arantza, Verheij, Joanne, de Boer, Onno J., Besselink, Marc G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Artificial intelligence Epithelium Life Sciences & Biomedicine Machine learning Nets Oncology Pancreatic cancer Patients Science & Technology Segmentation Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!